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OBJECTIVES This study evaluates the relevance of an enteroviral infection and the intramyocardial T-cell
immune response for the alteration in the adenine nucleotide translocator isoform transcrip-
tion pattern (ANTitp) in patients suspected of having myocardial inflammation.
BACKGROUND The ANT, the only mitochondrial carrier for ADP and ATP, plays a significant role in the
energy metabolism and is involved in the apoptosis process. Its function and expression were
found to be altered in the myocardium of patients with dilated cardiomyopathy and
myocarditis.
METHODS The ANTitp was analyzed in endomyocardial biopsies from 53 patients with clinically
suspected inflammatory heart disease (csIHD). Enteroviral RNA was detected in the biopsies
using the reverse transcripted polymerase chain reaction technique. The activation of the
cellular immune system was assessed by the quantification of T-lymphocytes employing
immunohistochemistry.
RESULTS The ANTitp was found to be altered in 21 csIHD patients. Enteroviral genome was found
in the heart of 71.4% of these patients, but only 37.5% of the patients with a normal ANTitp
were virus-positive (p , 0.02). The infiltration with CD31, CD45R01 and CD81 T-cells
was substantially lower in myocardial specimens with an altered ANTitp than in biopsies with
a normal ANTitp. Combining the data, an altered ANTitp was primarily found in
virus-positive heart tissue, which was less infiltrated with lymphocytes or not at all.
CONCLUSIONS An enteroviral infection is linked to changes in the ANT isoform expression in human heart
tissue, which shows little or no evidence of an active T-cell dependent immune response.
These results make a contribution to a better understanding of the pathophysiology of
enterovirus-induced human inflammatory heart disease. (J Am Coll Cardiol 2000;35:
1778–84) © 2000 by the American College of Cardiology
Enterovirus, especially Coxsackie B (CVB) subtypes, are
well known viral pathogens found in inflamed human hearts
(1,2). Coxsackie virus is a member of the picornavirus
family. In adults, CVB infections can cause active myocar-
ditis with acute heart failure, which in most cases heal up
spontaneously within the first four months. However, in
some cases chronic heart failure may supervene, leading to
the clinical diagnosis of dilated cardiomyopathy (DCM).
Many studies analyzed the interaction between the viral
infection and the immune system and its relevance for the
development of the heart failure (3,4). However, less is
known about the interaction of the viral infection and
intracellular biochemical and molecularbiological processes
in the infected heart tissue.
We recently reported an alteration in the function and
expression of the adenine nucleotide translocator (ANT) in
the myocardium of patients suffering from myocarditis or
DCM (5). The ANT is the only transport system that
enables the transfer of the energy-rich phosphates ADP and
ATP across the inner mitochondrial membrane (6). There-
fore, it represents the key link between the ATP production
in the mitochondria and the ATP consumption in the
cytosol. In addition, the ANT is significantly involved in the
apoptosis process, which is activated in inflamed hearts (7).
The ANT is a homodimeric protein and is encoded by three
distinct genes, designated as ANT1, ANT2 and ANT3
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(8,9). These genes were shown to be differently expressed in
various human tissues (10,11). The ANT function was
found to be impaired, and the total ANT-protein was
upregulated in heart tissue of patients suffering from DCM
(12). This dysfunction was accompanied by an alteration in
the expression profile of the three ANT isoforms (13). The
ANT isoform shift was characterized by an increased ANT1
and a decreased ANT2 proportion. These changes were
exclusively found in myocardial specimens of patients with
DCM and inflammatory heart disease but not with ischemic
or valvular/hypertrophic heart disease. Consequently,
changes in the function and expression of the ANT are not
a general phenomena of heart failure but seemed to be
specifically linked to viral induced heart disease.
A reduced ANT function was also observed in Coxsackie
B3 infected A/J mice, which was closely correlated to an
impaired heart function, indicating a potential pathophysi-
ological significance of the ANT in viral heart disease (14).
This study analyzed the relevance of the enterovirus and the
T-cell dependent immune response for the alteration in the
ANT isoform transcription pattern in human inflammatory
heart disease.
METHODS
Study groups. Fifty-three patients clinically suspected of
having inflammatory heart disease (csIHD) were enrolled in
this study (Table 1). Myocardial inflammation was pre-
sumed due to a typical history of previous viral infection at
the time of the onset of cardiac disease. The duration of
symptoms amounted to an average of 11 6 14 months.
Cardiac symptoms, such as cardiac arrhythmia, electrocar-
diographic changes and reduced exercise were observed. All
patients had left ventricular dysfunction with an ejection
fraction (EF) ,50% or a regional dysfunction with EF
.50%. The patients were examined by noninvasive and
invasive techniques including echocardiography, left ven-
triculography and right heart catheterization. Coronary,
hypertensive and valvular heart disease as well as restrictive
and constrictive heart disease were excluded as a cause for
the left ventricular dysfunction.
Endomyocardial right ventricular biopsies were taken
from the right ventricular septum of each patient by stan-
dard percutaneous transvenous right femoral approach using
a Cordis bioptome (Cordis, Haan, Germany).
It had previously been shown that the myocardial ANT
isoform pattern of patients suffering from ischemic cardio-
myopathy (ICM) did not differ from that of healthy people
(13). Therefore, explanted heart tissue from 22 patients with
ICM were used as controls. Samples were taken directly
after removal of the heart and immediately frozen in liquid
nitrogen. The specimens were stored at 280°C awaiting
analysis.
All procedures were performed in accordance with ethical
standards and with the Helsinki Declaration of 1975. All
patients gave their informed consent for all of the invasive
studies performed.
Determination of ANT isoform-specific mRNA propor-
tions. The ANT isoform transcription pattern was deter-
mined according to the method previously described in
detail by Do¨rner et al. (10).
Histology. Hematoxylin-eosin staining of paraffin sections
was carried out and analyzed according to standard methods
(15).
Immunohistological analysis. Cryostat sections were an-
alyzed for infiltrating T-lymphocytes, as previously pub-
lished (16). In brief, biopsy specimens were covered with
TissueTec embedding medium (Slee, Mainz, Germany)
and snap-frozen in methylbutane precooled in liquid nitro-
gen; 5 mm thick frozen sections were placed onto 10%
poly-L-lysine precoated slides. After blocking with 20%
Abbreviations and Acronyms
ANT 5 adenine nucleotide translocator
ANTitp 5 adenine nucleotide translocator isoform
transcription pattern
CBV 5 Coxsackie B virus
csIHD 5 clinically suspected inflammatory heart
disease
DCM 5 dilated cardiomyopathy
EF 5 ejection fraction
HPF 5 high power field
ICM 5 ischemic cardiomyopathy
Table 1. Clinical, Histological, Immunohistological and
Hemodynamic Characteristics of Patients With Clinically
Suspected Inflammatory Heart Disease (n 5 53)
Age (yrs) 47 6 14 (20–73)
Gender
Women 18
Men 35
Duration of symptoms (months) 11.4 6 14 (1–41)
Left ventriculographic variables
Ejection fraction (%) 48 6 21
Cardiac index (l/min/m2) 2.9 6 1
End-diastolic volume index
(ml/m2 BSA)
143 6 68
Stroke volume index (ml/m2 BSA) 60 6 22
Left ventricular end-diastolic pressure
(mm Hg)
15 6 8
Echocardiographic parameters
Left ventricular end-diastolic
diameter (mm)
63 6 12 (40–85)
Presence of enteroviral RNA 27
Histology
Acute myocarditis 2
Borderline myocarditis 9
Immunohistology
CD31 cells .7 per mm2 (20) 25
Data are shown as mean 6 SD or as number of patients. BSA 5 body surface area.
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fetal calf serum, tissue sections were incubated with mono-
clonal antibodies directed against CD31 (T-cells), CD41
(helper/inducer T-cells), CD81 (suppressor/cytotoxic
T-cells) and CD45R01 (activated T-lymphocytes and
memory T-cells) (Dianova, Germany). Detection of bound
antibodies was performed using peroxidase-conjugated an-
timouse and 3-amino-9-ethylcarbazol. Counterstaining was
performed with Mayer’s hemalaum solution, and sections
were mounted with Kaiser’s gelatine (Merk Darmstadt,
Germany).
Each biopsy was evaluated by two independent in-
vestigators. At least 10 high power fields (HPF) (1HPF 5
0.28 mm2) were examined at 4003 magnification. Increased
lymphocytic infiltration was defined as seven or more
CD3-positive cells mm2.
Analysis of the biopsies for enteroviral RNA. Enteroviral
RNA was detected by RT-PCR combined with a southern
blot hybridization as previously described by Pauschinger et
al. (17). In brief, total RNA isolated from the biopsies was
reverse transcribed into cDNA. Enteroviral specific cDNA
was amplified by PCR using primers (59Primer: 59CGG-
TACCTTTGTGCGCCTGT39; 39Primer: 59CAGGC-
CGCCAACGCAGCC39), which are located within the
59non-coding sequences area common for several enterovi-
ral subtypes. Enterovirus-specific sequences were detected
by southern blot analysis of the PCR products. Blots were
hybridized with a 59-P32 labeled oligonucleotide
(59CGAAGTAGTTGGCCGGATAAC39), which recog-
nizes enteroviral sequences.
Statistical analysis. Except when otherwise stated, data are
shown as mean 6 standard error of the mean (M 6 SEM).
Values were tested for normal distribution using the
Shapiro-Wilk W Test. The Mann-Whitney U test was
performed to test for statistical differences between two
groups. The Krushal-Wallis analysis of variance test in
ranks was used to compare more than two groups whose
data were not normally distributed, and the Dunn’s test was
subsequently performed as a multiple-comparison proce-
dure. Chi-square test was employed for the comparison of
qualitative data. A probability value , 0.05 indicated
statistical significance.
RESULTS
Patients. Fifty-three patients with clinically suspected in-
flammatory heart disease showing lasting symptoms over an
average of 11 6 14 months were enrolled in this study. All
patients had regional or global left ventricular dysfunction as
assessed by ventriculography and echocardiography. An
overview of the clinical data is given in Table 1. Biopsies of
27 patients were infected with enteroviral genome. The
histological investigation of the endomyocardial biopsies
resulted in the diagnosis of acute myocarditis for two and
borderline myocarditis for nine of the studied patients
tested. Immunohistological studies detected increased in-
tramyocardial T-lymphocyte infiltration in 25 of the en-
rolled patients. The duration of cardiac symptoms correlate
neither with virus persistence nor with the amount of
lymphocytes infiltrating the heart tissue of csIHD patients.
ANT isoform transcription pattern. The myocardial tran-
scription pattern of the three ANT isoforms in patients with
ischemic cardiomyopathy (ICM) (ANT1: 66.1 6 1.8%;
ANT2: 27.4 6 1.5%; ANT3: 6.5 6 0.7%; Fig. 1B) was
equal to the adenine nucleotide translocator isoform tran-
scription pattern (ANTitp) of people without any cardiac
disease, as previously reported (13). In order to describe the
ANT isoform pattern by the use of only one value and,
therefore, simplifying the presentation of the further data,
the ratio of ANT1:(ANT2 1 ANT3) mRNA was calcu-
lated. It amounted to an average of 2.2 6 0.5 (M 6 SD) for
the controls (Fig. 1A). The range of normal ANT isoform
composition was defined as the mean value of controls 6
3 3 SD (0.7–3.7). The group of patients with csIHD
showed a significantly higher myocardial ANT1:(ANT2 1
ANT3) mRNA ratio making up 3.6 6 2.3 (M 6 SD; p ,
0.02) than the controls. Twenty-one patients with csIHD
exceeded the upper limit of the normal isoform ratio
pointing to a shift in the ANT isoform pattern. This shift
was characterized by an increase in the ANT1 mRNA
(85 6 0.9%) and a decrease in the ANT2 (11.5 6 1%)
percentage (Fig. 1B). The ANT3 mRNA proportion was
only slightly lowered (3.5 6 0.4%). The alteration in the
ANTitp was not found to be correlated with the duration of
the disease.
Presence of enteroviral genome. None of the control
heart specimens were infiltrated with viral genome. In
contrast, enteroviral RNA was detected in endomyocardial
biopsies of 27 csIHD patients.
The ANT isoform mRNA pattern was analyzed in
relation to the presence of enteroviral mRNA in heart tissue
(Fig. 2). The average ANT1/ANT2 1 ANT3 mRNA ratio
of csIHD patients, found to have enteroviral genome in
their myocardial tissue, was seen to be increased to 4.5 6 0.5
and differed significantly from the controls (p , 0.001) and
from the group of virus-negative csIHD patients (p , 0.01).
In contrast, the myocardial ANT isoform transcription of
virus-negative csIHD was not significantly distinguished
from the controls (2.7 6 0.3 vs. 2.2 6 0.1). Enteroviral
genome was found in the heart biopsies of 15 from 21
csIHD with an altered ANTitp (71.4%). In contrast,
considerably less patients with a normal ANTitp were
virus-positive (12/32, p , 0.02). Only 6 of 26 virus-negative
patients (23%) were affected by a shift in the ANTitp.
Myocardial T-cell infiltration. The number of
T-lymphocyte in endomyocardial biopsies taken from pa-
tients with csIHD was determined by immunohistochemi-
cal technique and was correlated with the ANT isoform
transcription (Fig. 3). The maximum of normal intramyo-
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cardial CD31-cell amount had previously been defined to
be ,7 cells/mm2 (16). An excess of this limit reveals
evidence of an active T-cell dependent immune response.
The ANT isoform shift was negatively correlated with the
infiltration of the biopsies with CD31 T-cells (p , 0.001).
Endomyocardial specimens with a normal ANTitp were
significantly higher—infiltrated with CD3-positive lym-
phocytes—than those with an altered isoform pattern (Ta-
ble 2). Also, the amount of CD45R0-positive cells, reveal-
ing the presence of activated T-lymphocytes and T-memory
cells, was remarkably higher in biopsies with an unchanged
isoform. The myocardial infiltration with suppressor/
cytotoxic T-lymphocytes (CD81) and inducer/helper
T-cells (CD41) was found to be increased in tissue with a
normal ANTitp. These differences were statistically signif-
icant for CD81 and showed a trend for CD41.
ANT isoform transcription and CD31 lymphocytic in-
filtration of virus-positive biopsies. As seen in Figure 2,
not all of the 27 virus-positive csIHD patients showed an
alteration in the ANTitp. In order to elucidate the differ-
ences between the virus-positive patients with and without
an ANT isoform shift, respectively, we correlated the ANT
isoform transcription profile with the intramyocardial
CD31-cell infiltration of these patients (Fig. 4).
Fifteen virus-positive csIHD patients were found to be
affected by the shift in the myocardial ANTitp. Only two of
them showed an abnormally lymphocytic infiltration with
CD31 cells in their myocardium. In contrast, 75% (9/12) of
the endomyocardial biopsies from virus-positive csIHD
patients with a normal ANTitp were significantly infiltrated
Figure 1. (A) The ANT isoform transcription pattern of patients
with ICM (n 5 22) and csIHD (n 5 53) is described by its
ANT1/(ANT2 1 ANT3) mRNA ratio. Ischemic cardiomyopathy
patients were found to have an identical ANT isoform profile with
healthy people (13). Thus, the range of normal ANT isoform
distribution was defined as the mean 6 3 SD of the ICM patient’s
ratio and was marked by broken lines. The average percentage of
each ANT isoform found in the myocardium of patients with
csIHD that have an ANT1/ANT2 1 ANT3 mRNA ratio outside
the normal range (n 5 21; solid bars) are shown in comparison
with ICM patients (n 5 22; open bars) in graph (B). Data are
shown as means 6 SEM. ANT 5 adenine nucleotide translocator;
csIHD 5 clinically suspected inflammatory heart disease; ICM 5
ischemic cardiomyopathy.
Figure 2. The ANT isoform distribution, described by the ANT1/
ANT2 1 ANT3) mRNA ratio, is shown for patients with ICM
(n 5 22) and patients with csIHD whose biopsies were free from
enteroviral genome (virus-negative, n 5 26) or infiltrated with
enteroviral RNA (virus-positive, n 6 27). Broken lines mark the
range of normal ANT isoform distribution. Data are shown as
means 6 SEM. ANT 5 adenine nucleotide translocator;
csIHD 5 clinically suspected inflammatory heart disease; ICM 5
ischemic cardiomyopathy.
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with lymphocytes (p , 0.01). Consequently, most of the
csIHD patients with a normal ANTitp showed a remark-
able T-cell infiltration of their heart tissue, whereas an ANT
isoform shift was mainly observed in virus-positive biopsies
not penetrated with T-lymphocytes.
DISCUSSION
It was not until recently that interest focused on the
biochemical and molecularbiological processes taking place
in the enterovirus-infected myocardium (18,19). In connec-
tion with this, we recently found an alteration in the
myocardial ANT expression correlated with a restricted
ANT function in a significant number of patients suffering
from myocarditis and DCM (5). This study was designed to
enhance our understanding of the conjunction between the
enteroviral infection, the T-cell dependent immune re-
sponse and the shift in the ANT isoform transcription in
human inflammatory heart disease.
A myocardial altered ANT isoform mRNA pattern is
linked to an enteroviral infection. Acute myocarditis
induced by an enteroviral infection occurs during the first
two weeks. Within this time myocytolysis and virus clear-
ance take place. Depending on the genetic background of
the patients or the state of their immune system, myocar-
ditis either disappears spontaneously within the next four
months or becomes chronic. In the chronic phase, virus
persistence or the amount of infiltrating immunocompetent
cells was found to be independent of the duration of the
disease. These findings were confirmed in this study. The
interval between the onset of cardiac symptoms and biopsy
was not seen to be related either to the level of T-cell
infiltration or to the enteroviral infection or to the ANT
isoform shift. Therefore, data could be correlated indepen-
dently from the anamnestic onset of the disease.
Twenty-one of 53 patients with clinically suspected
inflammatory heart disease were found to be affected by a
shift in the ANT isoform pattern. The altered ANT isoform
profile was characterized by an increased ANT1, a decreased
ANT2 and a slightly lowered ANT3 mRNA proportion.
We found a close relation between the presence of
enteroviral RNA in the heart tissue and the shift in the
ANT isoform transcription. Seventy-one percent of the
Figure 3. The amount of CD3-positive T-cells infiltrating the
endomyocardial biopsies from patients with csIHD with a normal
(n 5 32) or an altered ANTitp (n 5 21). According to Ku¨hl et al.
(16), the normal range of intramyocardial T-cell infiltration was
defined to be ,7 cell/mm2. An excess of this limit, which is
marked by the broken line in the graph, shows a pathological
infiltration with T-cells. aANTitp 5 altered adenine nucleotide
translocator isoform transcription pattern; csIHD 5 clinically
suspected inflammatory heart disease; nANTitp 5 normal adenine
nucleotide translocator isoform transcription pattern.
Table 2. Amount of T-lymphocyte Subtypes Infiltrating the
Biopsies of Patients With a Normal or an Altered ANT
Isoform Transcription Pattern
T-Cell Subtype nANTitp aANTitp p Value
CD31 (cells/mm2) 12.0 6 2.3 6.1 6 1.0 ,0.01
CD45R01 (cells/mm2) 7.1 6 2.2 2.2 6 0.5 ,0.01
CD81 (cells/mm2) 8.2 6 2.2 3.1 6 0.2 ,0.01
CD41 (cells/mm2) 5.5 6 2.1 2.5 6 0.4 n.s.
aANTitp 5 altered adenine nucleotide translocator isoform pattern; nANTitp 5
normal adenine nucleotide translocator isoform pattern; n.s. 5 not statistically
significant.
Figure 4. The amount of CD3-specific cells infiltrating the heart
tissue of virus-positive patients with csIHD shown to have a
normal (n 5 12) or an altered ANTitp (n 5 15). According to
Ku¨hl et al. (16) the normal range of intramyocardial T-cell
infiltration was defined to be ,7 cell/mm2. aANTitp 5 altered
adenine nucleotide translocator isoform transcription pattern;
csIHD 5 clinically suspected inflammatory heart disease; nAN-
Titp 5 normal adenine nucleotide translocator isoform transcrip-
tion pattern.
1782 Do¨rner et al. JACC Vol. 35, No. 7, 2000
Virus Associated Shift in the ANT Isoform Pattern June 2000:1778–84
biopsies from csIHD patients with an altered myocardial
ANT isoform profile were infected with enteroviral RNA.
The connection between the changes in the ANT function
and expression and an enteroviral infection was confirmed
by our studies of Coxsackie B3 infected A/J mice (14). The
infection led to an increase in the intramitochondrial ATP
concentration and an accumulation of ADP in the cytosol of
the heart. This kind of imbalance in the intracellular
adenine nucleotide distribution is typical if the activity of
the ANT is impaired. Similar to human ischemic cardio-
myopathy, there was no alteration in the ANT function in
ischemic hearts of guinea pigs (20) or of spontaneous
hypertensive rats (unpublished data), making these changes
specific for an enterovirus-induced heart disease.
A few enterovirus-negative patients were also affected by
the ANT isoform shift. There may be subtypes of entero-
virus that were not identified by the technique used but are
able to influence the ANT isoform expression. In addition,
it has been shown that DNA virus, such as adenovirus (21)
of HIV virus (22), were found in inflamed human heart
tissue. The frequency of an adenoviral infection in patients
with clinically suspected myocarditis was found to be similar
to that of an enteroviral infection (21). Further studies are
required to clarify whether such viruses have a similar
capacity to induce an ANT isoform shift, indicating a
common mechanism in causing myocardial inflammation.
The ANT isoform shift is associated with an inactive
T-cell immune response. Studying the intracardial infil-
tration with immunocompetent cells in csIHD patients, we
found a remarkable inverse correlation between the in-
tramyocardial infiltration with T-lymphocytes and the al-
teration in the ANTitp. Heart tissue with a normal isoform
transcription was remarkably more penetrated by active
T-lymphocytes than myocardial tissue with an altered ANT
isoform distribution. An ANT isoform shift occurs espe-
cially in such tissue that is infected with enterovirus but less
infiltrated with T-lymphocytes. We, therefore, conclude
that an active cellular immune response produces conditions
that prevent the ANT isoform shift. This rescuing effect
may be a result of the elimination of the virus from the
myocardium. Subtyping the T-lymphocytes, infiltrating the
analyzed human biopsies, a significant increase in the
infiltration with (CD81) T-lymphocytes was found in the
heart tissue with a normal ANT isoform profile. In contrast
with this, the amount of CD41 cells was only somewhat
elevated. The relevance of cytotoxic/suppressor (CD81)
lymphocytes for the clearance of the virus from the tissue
has been demonstrated in murin myocarditis models and
especially in Coxsackie B3 infected CD8-knockout mice
(23,24). The exclusion of CD81 lymphocytes from the
cellular immune system resulted in an enormous increase in
the virus titer in the myocardium of the animals.
Mechanisms that might be responsible for the ANT
isoform shift. Even if the association between the entero-
viral infection and the change in the ANT expression is
evident, the mechanisms responsible for this alteration
remain unknown. Low-level CB3 gene expression without a
formation of infectious virus progeny was found to induce a
cytopathic effect in transfected myocytes, which was dem-
onstrated by a release of lactate dehydrogenase from trans-
fected myocytes (25). These findings support the opinion
that the virus is directly involved in the alteration in the
host’s gene expression. Other studies underline the assump-
tion that virus-induced autoimmunologic processes influ-
ence myocardial energy metabolism by depressing the ANT
function (26). Moreover, enterovirus stimulate the produc-
tion of cytokines and inflammatory mediators, such as NO,
which themselves induce changes in the biochemical and
molecular biological processes of myocytes. In the mouse
model of chronic viral myocarditis, a progressive expression
of IL1 beta, IL6, TNFa was shown when most histological
signs of inflammation had subsided (27). Cytokines and
NO were shown to cause a time-dependent induction of
cardiac myocyte apoptosis (28) in which the ANT plays an
important role (7). Such an elevated expression of cytokines,
such as TNF alpha, IL1 beta, IL6, IL8 and NO was also
observed in the myocardium of patients with myocarditis
and DCM (29–31).
Consequences of an altered ANT function and expres-
sion for the heart. Previous studies have demonstrated that
the shift in the transcription pattern is also seen on the
protein level shown by an increase in the ANT1 and the
total ANT protein amount (7). The change in the ANT
protein amount was accompanied by a decrease in the
transport capacity of the ANT (12). A disturbed energy
metabolism and an impaired heart function was shown to be
a consequence of an altered ANT expression and function in
animal models, such as ANT1 knockout mice (32) and
Coxsackie B3 infected mice (14). In these cases myocardial
dysfunction was a result of a lowered ATP supply. However,
the ANT is also highly involved in the apoptosis process
(33). It is a member of the permeability transition pore and
an important receptor for apoptosis-regulating proteins of
the Bcl-2 protein family (7). Thus, changed ANT expres-
sion might not only influence the energy metabolism but
also the apoptotic process. Apoptosis was seen to be active
in enterovirus infected heart tissue (34) and is supposed to
play a significant role in human heart failure.
Other genes, coding for proteins that are involved in
apoptosis, signal transduction pathway, regulation of gene
expression and oxidative phosphorylation were also found to
be differently expressed in Coxsackie B3-infected mice (35).
The altered ANT gene expression thus appeared to be a
feature of a specific gene program activated in enterovirus-
infected hearts.
The data led to the conclusion that the virus itself, or
factors that are activated by virus-infection, influence the
ANT isoform expression in heart tissue, which show less or
no evidence of an active T-cell dependent immune response.
In view of the significance of the ANT for complex
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intracellular processes, such as the energy metabolism and
apoptosis, alterations in the ANT expression and function
may be involved in the pathophysiology of viral heart
disease.
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